NEW YORK, Feb. 22, 2018 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aflac Incorporated ("Aflac" or the "Company") (NYSE:AFL) and certain of its officers, on behalf of shareholders who purchased Aflac securities during the period between February 27, 2013 and January 11, 2018, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/afl.
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
The complaint alleges that throughout the Class Period, defendants made materially false and misleading statements and/or failed to disclose that: (1) Aflac hired its sales associates under false promises of high compensation packages and work- life-balance; (2) Aflac misclassified its employees as independent contractors to reduce costs associated with unemployment insurance taxes and employment benefits; (3) Aflac manipulated its average weekly producer equivalent metric to fabricate growth; (4) consequently, Aflac violated its Code of Conduct and corporate social responsibility standards, and (5) as a result of the foregoing, Aflac’s public statements were materially false and misleading at all relevant times.
On January 11, 2018, post-market, The Intercept published an article entitled “Behind the Duck: Former Aflac Employees Allege Fraud and Abuse in Nearly Every Aspect of Company.” Citing “interviews with multiple current and former employees, as well as three previously unreported lawsuits,” the article reported that “Aflac has exploited workers, manipulated its accounting, and deceived shareholders and customers.” Among other issues, the article described “employees under pressure to meet sales goals selling policies without customer authorization or consent, illegally ‘bundling’ policies, and issuing others to ineligible customers”; the Company’s “[m]assaging of key operational metrics to prove company growth to investors”; “[e]arnings statement manipulation, by moving sales earned in certain weeks into different quarters to hit numbers”; and “[r]etaliation against whistleblowers”. On this news, Aflac’s share price has fallen sharply during intra-day trading on January 12, 2018.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/afl or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]


Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
OpenAI Restricts Astra AI Over Cyberattack Risks
ADNOC Gas Targets Up to $4B Profit in 2026
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
Goldman Sachs Sees US Stock Buybacks Outpacing Equity Issuance as AI Funding Rises
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook
DeepSeek to Raise AI API Prices as Demand for New Models Surges
Shein Scales Back Vietnam Operations as US Trade Rules Shift
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns 



